{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:01:33Z","timestamp":1780030893864,"version":"3.53.1"},"reference-count":13,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ANZ Journal of Surgery"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The most common technique for sentinel node localisation is technetium\u201099m (Tc\u201099m) injection. Tc\u201099m is typically administered in a nuclear medicine department, causing logistical challenges in regional hospitals. This study compares outcomes of surgeon\u2010administered Tc\u201099m injection with the nuclear medicine injection technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective review was conducted of patients undergoing sentinel lymph node biopsy for breast cancer at Tauranga Hospital between July 2021 and July 2023. Prior to July 2022, patients travelled to a tertiary hospital for their Tc\u201099m injection. From July 2022, the surgical team administered the injection. Patients were excluded if neoadjuvant therapy received, axillary dissection performed due to lymph node metastases on frozen section, or if insufficient information was recorded. Radioactivity signal was assessed before commencing the operation, with patent blue dye injected if no signal detected. Outcomes included blue dye requirement and number of nodes harvested.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty\u2010five patients were included in the nuclear medicine injected group and 97 in the surgeon injected group. All patients in the surgeon injected group received Tc\u201099m. Despite referral for the nuclear medicine procedure, 21% of patients did not receive Tc\u201099m in the nuclear medicine injected group. Blue dye use was significantly lower in the surgeon injected group (17.5% vs. 36.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). Mean number of nodes harvested did not differ significantly (3.24 vs. 3.77,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.076). The localisation rate using Tc\u201099m alone in the surgeon injected group was 93%, which was within the range quoted in the literature.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Preoperative surgeon\u2010administered Tc\u201099m injection improved accessibility and significantly reduced the need for blue dye without compromising sentinel node localisation or lymph node yield.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ans.70529","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:19:23Z","timestamp":1771057163000},"page":"1186-1189","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surgeon Injected Technetium\u201099m for Sentinel Lymph Node Biopsies in Breast Cancer\u2014Outcomes in a Regional Hospital"],"prefix":"10.1111","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-3526","authenticated-orcid":false,"given":"Anna","family":"Sandstrom","sequence":"first","affiliation":[{"name":"Tauranga Hospital  Tauranga New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2792-672X","authenticated-orcid":false,"given":"Nicola","family":"Davis","sequence":"additional","affiliation":[{"name":"Tauranga Hospital  Tauranga New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05843-8"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2011.10.006"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1308\/rcsann.2012.94.4.277a"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.12.007"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15245755"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09280-1"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-008-0010-3"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5924802"},{"key":"e_1_2_9_10_1","unstructured":"M.MahadikandN.Davis \u201cReview of Radio\u2010Isotope Use in a Regional Hospital Following Administration in a Tertiary Centre \u201dRACS ASC 2021; Abstract ID: 4358 (Tauranga Hospital Bay of Plenty New Zealand: 2021)."},{"issue":"4","key":"e_1_2_9_11_1","first-page":"263","article-title":"Intraoperative Injection of Subareolar or Dermal Radioisotope Results in Predictable Identification of Sentinel Lymph Nodes in Breast Cancer","volume":"41","author":"Johnson C. B.","year":"2013","journal-title":"Journal of Nuclear Medicine Technology"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.01.006"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0075-7"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(99)00230-5"}],"container-title":["ANZ Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ans.70529","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ans.70529","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ans.70529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:06:19Z","timestamp":1780027579000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ans.70529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1111\/ans.70529"],"URL":"https:\/\/doi.org\/10.1111\/ans.70529","archive":["Portico"],"relation":{},"ISSN":["1445-1433","1445-2197"],"issn-type":[{"value":"1445-1433","type":"print"},{"value":"1445-2197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"2025-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}